Emerging Targeted Therapies for Early Breast Cancer Ilana SchlamPaolo TarantinoSara M. Tolaney Review Article 07 October 2022 Pages: 1437 - 1451
Inhaled Corticosteroids in Adults with Non-cystic Fibrosis Bronchiectasis: From Bench to Bedside. A Narrative Review Miguel Ángel Martínez-GarcíaGrace OsculloMario Cazzola Review Article Open access 20 October 2022 Pages: 1453 - 1468
The Effect of Oral Antidiabetic Drugs on Improving the Endocrine and Metabolic States in Women with Polycystic Ovary Syndrome: A Systematic Review and Network Meta-analysis Shuo YangLu ZhaoYaochuan Mi Systematic Review 21 September 2022 Pages: 1469 - 1480
Varenicline Solution Nasal Spray: A Review in Dry Eye Disease James E. Frampton Adis Drug Evaluation 05 October 2022 Pages: 1481 - 1488
Cabotegravir Extended-Release Injectable Suspension: A Review in HIV-1 Pre-Exposure Prophylaxis Hannah A. Blair Adis Drug Evaluation 18 October 2022 Pages: 1489 - 1498
Lenacapavir: First Approval Julia Paik AdisInsight Report Open access 22 October 2022 Pages: 1499 - 1504
Valoctocogene Roxaparvovec: First Approval Hannah A. Blair AdisInsight Report 10 October 2022 Pages: 1505 - 1510
Comment on: Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations Katsuhiro Toda Letter to the Editor 18 October 2022 Pages: 1511 - 1512
Authors’ Reply to Toda: Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations Nicola VeroneseJean-Yves Reginster Letter to the Editor 18 October 2022 Pages: 1513 - 1514